BioSpace News Archive

Business

Verge Genomics Announces Artificial Intelligence-Enabled Drug Discovery Collaboration with Alexion for Rare Neurodegenerative and Neuromuscular Diseases

Verge Genomics today announced a multi-target collaboration with Alexion, AstraZeneca Rare Disease (“Alexion”) to identify novel drug targets for rare neurodegenerative and neuromuscular diseases.

September 8, 2023

·

3 min read

Genetown

Rhythm Pharmaceuticals Announces Update to September 2023 Conference Participation

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with hyperphagia and severe obesity caused by rare melanocortin-4 receptor pathway diseases, announced an update to its September conference calendar.

September 8, 2023

·

8 min read

Genetown

Ardelyx to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Ardelyx, Inc. (Nasdaq: ARDX) today announced that Mike Raab, president and chief executive officer of Ardelyx, will present at the H.C. Wainwright 25th Annual Global Investment Conference on Monday, September 11, 2023, at 12:00 p.m. ET in New York City.

September 8, 2023

·

1 min read

Deals

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)-September 8, 2023

UroGen Pharma Ltd. today announced the grants of inducement restricted stock units (“RSUs”) to 11 new employees, as well as options (“Options”) to one of the new employees, in connection with their employment with UroGen.

September 8, 2023

·

2 min read

Brainomix Partners with TIPAL Trial to Assess Its Novel IPF Biomarker in Lung Disease

The company will apply its cutting-edge AI technology to run a sub-study assessing the value of its novel imaging biomarkers

September 8, 2023

·

3 min read

Drug Development

BioRestorative Therapies Announces Activation of Northwell Health in the Company’s Phase 2 Clinical Trial Targeting Chronic Lumbar Disc Disease

BioRestorative Therapies, Inc . today announced that Northwell Health, New York State’s largest health care provider has been activated and can now start recruitment in the State of New York for BioRestorative’s ongoing Phase 2 clinical trial targeting chronic lumbar disc disease (“cLDD”).

September 8, 2023

·

5 min read

Drug Development

CorMedix Inc. Announces Publication of Phase 3 LOCK IT-100 Study Data in the Clinical Journal of The American Society of Nephrology

CorMedix Inc. today announced the publication of its Phase 3 LOCK IT-100 study results in the Clinical Journal of the American Society of Nephrology, or CJASN.

September 8, 2023

·

4 min read

Drug Development

Parion Sciences Announces Publication of Phase 2 CLEAN-PCD Study in The Lancet Respiratory Medicine

Parion Sciences Inc. today announced publication in The Lancet Respiratory Medicine of positive results of the Phase 2 study of idrevloride in hypertonic saline in people with primary ciliary dyskinesia (PCD).

September 8, 2023

·

5 min read

Biotech Bay

Kyverna Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

Kyverna Therapeutics (“Kyverna”), announced today its participation in the Morgan Stanley 21st Annual Global Healthcare Conference to be held in New York, NY, on September 11-13, 2023.

September 8, 2023

·

1 min read

Pharm Country

Intelligent Bio Solutions Completes Critical Development Milestone in Plans to Add Ketamine and Tramadol to Fingerprint Drug Test

Intelligent Bio Solutions Inc. today announced the successful completion of a key development milestone in its plans to add ketamine and tramadol to its Intelligent Fingerprinting Drug Screening System.

September 8, 2023

·

5 min read